GINKGO BIOWORKS HOLDINGS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $13.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $6.14M, a 17.95% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $7.11M, a 3.59% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $7.63M, a 2.10% increase year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $7.58M, a 0.45% increase year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $30.08M, a 7.07% increase from fiscal 2024.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $28.09M, a 0.77% decline from fiscal 2023.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $28.31M, a 48.38% increase from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $19.08M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.26M 10-Q · filed 2026-08-06 | $20.89M derived: sum of 3 quarters · filed 2026-08-06 | $28.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.11M 10-Q · filed 2026-05-07 | $14.75M derived: sum of 2 quarters · filed 2026-05-07 | $22.33M derived: sum of 3 quarters · filed 2026-05-07 | $29.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.22M derived: sum of 2 quarters · filed 2026-02-26 | $22.70M derived: sum of 3 quarters · filed 2026-08-06 | $30.08M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.07M derived: sum of 2 quarters · filed 2026-08-06 | $22.45M 10-Q · filed 2025-11-06 | $29.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.87M 10-Q · filed 2026-08-06 | $22.34M derived: sum of 3 quarters · filed 2026-08-06 | $29.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.38M 10-Q · filed 2026-05-07 | $14.86M derived: sum of 2 quarters · filed 2026-05-07 | $22.40M derived: sum of 3 quarters · filed 2026-05-07 | $29.84M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.03M derived: sum of 2 quarters · filed 2026-02-26 | $22.46M derived: sum of 3 quarters · filed 2026-02-26 | $28.09M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.98M derived: sum of 2 quarters · filed 2025-11-06 | $20.62M 10-Q · filed 2025-11-06 | $24.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $7.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $13.07M 10-Q · filed 2025-08-07 | $16.75M derived: sum of 3 quarters · filed 2026-02-26 | $25.06M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $5.64M 10-Q · filed 2025-05-06 | $9.31M derived: sum of 2 quarters · filed 2026-02-26 | $17.62M derived: sum of 3 quarters · filed 2026-02-26 | $25.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.99M derived: sum of 2 quarters · filed 2026-02-26 | $20.27M derived: sum of 3 quarters · filed 2026-02-26 | $28.31M 10-K · filed 2026-02-26 |
| 2023-09-30 | $8.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $16.60M derived: sum of 2 quarters · filed 2024-11-12 | $24.64M 10-Q · filed 2024-11-12 | $31.84M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $16.33M 10-Q · filed 2024-08-08 | $23.53M derived: sum of 3 quarters · filed 2025-02-25 | |
| 2023-03-31 | $8.04M 10-Q · filed 2024-05-09 | $15.24M derived: sum of 2 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $19.08M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $11.88M 10-Q · filed 2023-11-08 |